These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 444293)

  • 1. Cumulative effects of irreversible MAO inhibitors in vivo.
    Felner AE; Waldmeier PC
    Biochem Pharmacol; 1979 Apr; 28(7):995-1002. PubMed ID: 444293
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of monoamine oxidases. Inhibition of bovine brain MAO in intact mitochondria by tricyclic antidepressant drugs.
    Achee FM; Gabay S
    Biochem Pharmacol; 1979 Apr; 28(7):1197-203. PubMed ID: 444277
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 6. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
    Garrick NA; Murphy DL
    Psychopharmacology (Berl); 1980; 72(1):27-33. PubMed ID: 6781004
    [No Abstract]   [Full Text] [Related]  

  • 7. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of MAO inhibitors using postmortem human brain tissue: biochemical and therapeutic implications.
    Reynolds GP; Riederer P
    Mod Probl Pharmacopsychiatry; 1983; 19():255-9. PubMed ID: 6408410
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG; Baker GB
    J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
    Clement HW; Grote C; Wesemann W
    J Neural Transm Suppl; 1990; 32():85-8. PubMed ID: 2128514
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenylethanolamine is a specific substrate for type B monoamine oxidase.
    Edwards DJ
    Life Sci; 1978 Sep; 23(11):1201-7. PubMed ID: 713694
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands.
    Lalies MD; Hibell A; Hudson AL; Nutt DJ
    Ann N Y Acad Sci; 1999 Jun; 881():114-7. PubMed ID: 10415906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.